In contrast, no difference in tumor growth was observed after the adoptive transfer of previously activated CD8+ lymphocytes from either a RELT−/− or WT background, supportive of a model in which RELT inhibits the activation of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.